Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)

NCT05893056 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer Metastatic to Liver

Interventions

PROCEDURE: Cryoablation
DRUG: Tislelizumab
DRUG: Lenvatinib

Sponsor

Fudan University